Compile Data Set for Download or QSAR
Report error Found 162 Enz. Inhib. hit(s) with all data for entry = 10912
TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 7nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 8nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 50245478BDBM50245478(CHEMBL4081588 | US11472838, Compound Ref. 25)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577537BDBM577537(US11472838, Compound Ref. 14)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577509BDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577546BDBM577546(US11472838, Compound Ref. 21)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577540BDBM577540(US11472838, Compound Ref. 16)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577484BDBM577484(US11472838, Compound 1a/b)
Affinity DataIC50: 11nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577511BDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50: 12nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577488BDBM577488(US11472838, Compound 6)
Affinity DataIC50: 12nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577487BDBM577487(US11472838, Compound 4)
Affinity DataIC50: 13nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577487BDBM577487(US11472838, Compound 4)
Affinity DataIC50: 14nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577512BDBM577512(US11472838, Compound 30)
Affinity DataIC50: 15nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 15nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 15nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Pig)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577512BDBM577512(US11472838, Compound 30)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577485BDBM577485(US11472838, Compound 2a/b)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577486BDBM577486(US11472838, Compound 3)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577488BDBM577488(US11472838, Compound 6)
Affinity DataIC50: 17nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577506BDBM577506(US11472838, Compound 24a/b)
Affinity DataIC50: 18nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 19nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 19nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577507BDBM577507(US11472838, Compound 25a/b)
Affinity DataIC50: 20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577486BDBM577486(US11472838, Compound 3)
Affinity DataIC50: 20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577490BDBM577490(US11472838, Compound 8a/b)
Affinity DataIC50: 21nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577489BDBM577489(US11472838, Compound 7a/b)
Affinity DataIC50: 21nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577511BDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50: 24nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577496BDBM577496(US11472838, Compound 14a/b)
Affinity DataIC50: 26nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577529BDBM577529(US11472838, Compound Ref. 09)
Affinity DataIC50: 26nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577509BDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50: 27nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577509BDBM577509(US11472838, Compound 27 | US11472838, Compound 31a...)
Affinity DataIC50: 27nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577483BDBM577483(US11472838, Compound 5)
Affinity DataIC50: 28nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577511BDBM577511(US11472838, Compound 29 | US11472838, Compound 32a...)
Affinity DataIC50: 32nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577526BDBM577526(US11472838, Compound Ref. 7)
Affinity DataIC50: 32nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577507BDBM577507(US11472838, Compound 25a/b)
Affinity DataIC50: 35nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577547BDBM577547(US11472838, Compound 45a/b)
Affinity DataIC50: 35nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577527BDBM577527(US11472838, Compound Ref. 08)
Affinity DataIC50: 36nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandChemical structure of BindingDB Monomer ID 577510BDBM577510(US11472838, Compound 28)
Affinity DataIC50: 36nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

LigandChemical structure of BindingDB Monomer ID 577492BDBM577492(US11472838, Compound 10a/b)
Affinity DataIC50: 38nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
US Patent

Displayed 1 to 50 (of 162 total ) | Next | Last >>
Jump to: